Èèyàn èyíkéyìí lè ní àrùn jẹjẹrẹ ẹ̀dọ̀fóró, àmọ́ àwọn nǹkan kan wà tó lè mú kí ewu tó wà fún àìsàn náà pọ̀ sí i.
Lára àwọn nǹkan wọ̀nyí ni:
1. Èéfín mímu: Èéfín mímu ni olórí ohun tó ń fa àrùn jẹjẹrẹ ẹdọfóró.
Bí ẹnì kan bá ṣe ń mu sìgá tipẹ́tipẹ́ àti bí wọ́n bá ṣe ń mu sìgá tó pọ̀ tó, bẹ́ẹ̀ ni ewu tó wà fún un máa ń pọ̀ sí i.
2. Èéfín tí ẹnì kan ń mu: Èéfín tí ẹnì kan ń mu tún lè mú kí àrùn jẹjẹrẹ ẹ̀dọ̀fóró pọ̀ sí i.
3. Èéfín radon: Èéfín radon, tó jẹ́ gáàsì tó ń ràn káàkiri tó lè kóra jọ nínú ilé, lè mú kí àrùn jẹjẹrẹ ẹ̀dọ̀fóró pọ̀ sí i.
4. Asbestos àti àwọn èròjà mìíràn tó ń fa àrùn jẹjẹrẹ: Tó o bá ní asbestos, arsenic, chromium, nickel, àtàwọn èròjà mìíràn, ó lè mú kó o ní àrùn jẹjẹrẹ ẹdọfóró.
5. Ìbàjẹ́ afẹ́fẹ́: Ìbàjẹ́ afẹ́fẹ́ fún àkókò gígùn lè mú kí ewu àrùn jẹjẹrẹ ẹdọfẹ́ pọ̀ sí i.
6. Ìtàn Ìdílé: Ìtàn Ìdílé nípa àrùn jẹjẹrẹ ẹ̀dọ̀fóró lè mú kí ewu àrùn náà pọ̀ sí i.
7. Ọ̀dọ́mọkùnrin: Bí ọjọ́ ṣe ń gorí ọjọ́, bẹ́ẹ̀ ni ewu àrùn jẹjẹrẹ ẹ̀dọ̀fóró máa ń pọ̀ sí i, èyí tó pọ̀ jù lọ lára wọn sì jẹ́ àwọn tó ti pé ọmọ ọdún 65.
8. Ẹ̀yà ara: Àwọn ọkùnrin sábà máa ń ní àrùn jẹjẹrẹ ẹdọfóró ju àwọn obìnrin lọ.
9. Ìtàn ara ẹni nípa àìsàn ẹdọfóró: Àwọn èèyàn tí wọ́n ní ìtàn nípa àìsàn ẹdọfóró bíi àìsàn ẹdọfóró tó ń fa àìsàn àìsàn àìsàn àìsàn àìsàn àìsàn àìsàn àìsàn àìsàn àìsàn àìsàn àìsàn àìsàn àìsàn àìsàn àìsàn àìsàn àìsàn àìsàn.
10. Ìtọ́jú Ìmọ́lẹ̀ sí Àyà: Àwọn tó ti gba ìtọ́jú Ìmọ́lẹ̀ sí Àyà fún àwọn àrùn jẹjẹrẹ mìíràn ní ewu tó pọ̀ sí i láti ní àrùn jẹjẹrẹ ẹdọfóró.
Ó ṣe pàtàkì láti kíyè sí i pé kì í ṣe gbogbo ẹni tó bá ní àwọn ohun tó ń fa àrùn náà ló máa ní àrùn jẹjẹrẹ ẹdọfóró, àwọn kan tó bá sì ní àrùn jẹjẹrẹ ẹdọfóró lè má ní àwọn ohun tó ń fa àrùn náà.
Couraud S, Grolleau E: [How to implement lung cancer screening ?] Rev Prat. 2020, 70 (8): 864-867.
Casutt A, Lovis A, Selby K, Noirez L, Peters S, Beigelman-Aubry C, Krueger T, Soccal PM, Von Garnier C: [Lung cancer screening in Switzerland : Who ? How ? When ?] Rev Med Suisse. 2020, 16 (715): 2224-2226.
Peres J: Lung cancer screening gets risk-specific. J Natl Cancer Inst. 2013, 105 (1): 1-2.
McNeil C: Combined therapy for lung cancer gets a boost. J Natl Cancer Inst. 1996, 88 (17): 1182-4.
Rubino C, de Vathaire F, Diallo I, Shamsaldin A, Grimaud E, Labbe M, Contesso G, Le M: Radiation dose, chemotherapy and risk of lung cancer after breast cancer treatment. Breast Cancer Res Treat. 2002, 75 (1): 15-24.
Ali Mohammed Hammamy R, Farooqui K, Ghadban W: Sclerotic Bone Metastasis in Pulmonary Adenocarcinoma. Case Rep Med. 2018, 2018 (): 1903757.
Wu J, Ma L, Wang J, Qiao Y: [Mechanism of Ferroptosis and Its Research Progress in Lung Cancer]. Zhongguo Fei Ai Za Zhi. 2020, 23 (9): 811-817.
Cancer Screening Gets Thumbs-up From Readers. Manag Care. 2017, 26 (5): 30-31.
Ìyàsímímọ́: ìtọ́jú ìlera
Oju opo wẹẹbu yii ni a pese fun eto-ẹkọ ati awọn idi alaye nikan ati pe ko ṣe agbekalẹ pese imọran iṣoogun tabi awọn iṣẹ ọjọgbọn.
A ò gbọ́dọ̀ lo ìsọfúnni tó wà nínú ìwé náà láti ṣe àyẹ̀wò tàbí láti wo àìsàn tàbí àìsàn kan wò, àwọn tó bá sì ń wá ìmọ̀ràn nípa ìṣègùn fúnra wọn gbọ́dọ̀ bá dókítà tó ní ìwé àṣẹ sọ̀rọ̀.
Jọwọ ṣe akiyesi nẹtiwọọki neural ti o ṣe agbejade awọn idahun si awọn ibeere, jẹ pataki ti ko tọ nigbati o ba de si akoonu nọmba. Fun apẹẹrẹ, nọmba awọn eniyan ti a ṣe ayẹwo pẹlu aisan kan pato.
Nigbagbogbo wa imọran ti dokita rẹ tabi olupese ilera ti o ni oye miiran nipa ipo iṣoogun kan. Maṣe gbagbe imọran iṣoogun ọjọgbọn tabi idaduro ni wiwa rẹ nitori nkan ti o ti ka lori oju opo wẹẹbu yii. Ti o ba ro pe o le ni pajawiri iṣoogun, pe 911 tabi lọ si yara pajawiri ti o sunmọ julọ lẹsẹkẹsẹ. Ko si ibatan dokita-aisan ti a ṣẹda nipasẹ oju opo wẹẹbu yii tabi lilo rẹ. Bẹni BioMedLib tabi awọn oṣiṣẹ rẹ, tabi ẹnikẹni ti o ṣe alabapin si oju opo wẹẹbu yii, ṣe eyikeyi awọn aṣoju, ṣalaye tabi tumọ, pẹlu ọwọ si alaye ti a pese nibi tabi lilo rẹ.
Ìyàsímímọ́: ẹ̀tọ́ ọmọnìyàn
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the DMCA) n pese atunṣe fun awọn onihun aṣẹ-aṣẹ ti o gbagbọ pe ohun elo ti o han lori Intanẹẹti ṣe ilokulo awọn ẹtọ wọn labẹ ofin aṣẹ-aṣẹ AMẸRIKA.
Ti o ba gbagbọ ni igbagbọ to dara pe eyikeyi akoonu tabi ohun elo ti o wa ni asopọ pẹlu oju opo wẹẹbu wa tabi awọn iṣẹ ṣe ilokulo aṣẹ-aṣẹ rẹ, iwọ (tabi aṣoju rẹ) le firanṣẹ akiyesi kan si wa ti o beere pe a yọ akoonu tabi ohun elo naa kuro, tabi idilọwọ iraye si rẹ.
A gbọdọ firanṣẹ awọn iwifunni ni kikọ nipasẹ imeeli (wo abala "Ibaṣepọ" fun adirẹsi imeeli).
DMCA nilo pe akiyesi rẹ ti ilokulo aṣẹ-aṣẹ ti a fi ẹsun kan pẹlu alaye wọnyi: (1) apejuwe ti iṣẹ ti o ni aṣẹ-aṣẹ ti o jẹ koko-ọrọ ti ilokulo ti a fi ẹsun kan; (2) apejuwe ti akoonu ti a fi ẹsun kan ati alaye ti o to lati gba wa laaye lati wa akoonu naa; (3) alaye olubasọrọ fun ọ, pẹlu adirẹsi rẹ, nọmba foonu ati adirẹsi imeeli; (4) alaye nipasẹ rẹ pe o ni igbagbọ rere pe akoonu ni ọna ti o ni ẹsun ti ko ni aṣẹ nipasẹ eni aṣẹ-aṣẹ, tabi aṣoju rẹ, tabi nipasẹ iṣẹ ti ofin eyikeyi;
(5) ìpolongo kan láti ọ̀dọ̀ rẹ, tí o fìdí rẹ̀ múlẹ̀ lábẹ́ ìjìyà ẹ̀rí èké, pé ìsọfúnni tó wà nínú ìkéde náà tọ̀nà àti pé o ní àṣẹ láti mú kí àwọn ẹ̀tọ́ ọmọnìyàn tí wọ́n sọ pé wọ́n ti rú ṣẹ ṣẹ;
ati (6) ibuwọlu ti ara tabi itanna ti ẹni ti o ni aṣẹ tabi eniyan ti o ni aṣẹ lati ṣiṣẹ ni orukọ ẹni ti o ni aṣẹ.
Ti o ko ba ṣafikun gbogbo alaye ti o wa loke le ja si idaduro ti ṣiṣe ẹdun rẹ.
Ìfọ̀rọ̀wérọ̀
Jọwọ fi imeeli ranṣẹ si wa pẹlu eyikeyi ibeere / imọran.
Who gets lung cancer?
Lung cancer can affect anyone, but certain factors can increase the risk of developing the disease.
These include:
1. Smoking: Smoking is the leading cause of lung cancer.
The longer a person smokes and the more cigarettes they smoke, the greater their risk.
2. Secondhand smoke: Exposure to secondhand smoke can also increase the risk of lung cancer.
3. Radon gas: Exposure to radon gas, a naturally occurring radioactive gas that can accumulate in homes, can increase the risk of lung cancer.
4. Asbestos and other carcinogens: Exposure to asbestos, arsenic, chromium, nickel, and other substances can increase the risk of lung cancer.
5. Air pollution: Long-term exposure to air pollution can increase the risk of lung cancer.
6. Family history: A family history of lung cancer may increase a person's risk.
7. Age: The risk of lung cancer increases with age, with most cases occurring in people over the age of 65.
8. Gender: Men are more likely to develop lung cancer than women.
9. Personal history of lung disease: People with a history of lung diseases such as chronic obstructive pulmonary disease (COPD) or tuberculosis may have an increased risk of lung cancer.
10. Radiation therapy to the chest: People who have had radiation therapy to the chest for other cancers have an increased risk of lung cancer.
It is important to note that not everyone with risk factors will develop lung cancer, and some people who do develop lung cancer may not have any known risk factors.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
Ní nǹkan bí
BioMedLib nlo awọn kọnputa adaṣe (awọn alugoridimu ẹkọ ẹrọ) lati ṣe agbejade awọn tọkọtaya ibeere ati idahun.
A bẹrẹ pẹlu awọn atẹjade biomedical miliọnu 35 ti PubMed/Medline. Pẹlupẹlu, awọn oju-iwe wẹẹbu ti RefinedWeb.
